Expert Opinion on Drug Delivery

Papers
(The TQCC of Expert Opinion on Drug Delivery is 13. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-06-01 to 2026-06-01.)
ArticleCitations
How can nanoemulsions be used for photosensitizer drug delivery?115
A tale of nucleic acid–ionizable lipid nanoparticles: Design and manufacturing technology and advancement88
Calcium phosphate coated nanoparticles for drug delivery: where are we now?81
Challenges and opportunities in neurometabolic disease treatment with enzyme delivery71
Dose accuracy of the follitropin alfa pen injector 2.0, the follitropin alfa:lutropin alfa 2:1 combination pen injector 2.0 and the choriogonadotropin alfa pen injector 1.0 used for fertility treatmen67
Receptor-mediated nose-to-brain delivery of drug combination-loaded polymeric nanocarriers for the treatment of glioblastoma- current progress and future perspectives part II: polymeric nanocarriers f61
Artificial Intelligence’s role in colon-targeted drug delivery60
All eyes on semifluorinated alkanes: a comprehensive review of the influence of semifluorinated alkane eyedrops on tear film stabilization and drug delivery in dry eye disease56
Iontophoresis for the cutaneous delivery of nanoentraped drugs56
The quest to deliver high-dose rifampicin: can the inhaled approach help?53
Needle-free injection of basal insulin improves fasting glucose variability as assessed by continuous glucose monitoring in T2DM: a prospective randomized multicenter open-label crossover study53
Brain delivery enabled by transient blood–brain barrier disruption induced by regadenoson: a PET imaging study53
Intranasal delivery of glucagon-like peptide-1 to the brain for obesity treatment: opportunities and challenges50
An update on the port delivery system with ranibizumab for retinal diseases50
Theranostic metallic nanoconjugates for colorectal cancer: targeting strategies, imaging modalities, and translational challenges49
Assessment of adherence to, and persistence with, an electromechanical autoinjector for subcutaneous interferon beta-1a injections for multiple sclerosis treatment over 3 years45
Nanominerals: a multifaceted biomaterial for regenerative medicine and drug delivery44
Pre-ANDA strategy and Human Factors activities to de-risk pharmaceutical companies ANDA submission of drug–device combination products: case study of a formative Comparative Use Human Factors study42
Self-assembled structures of ascorbic acid derivatives: encapsulation properties and controlled drug delivery applications41
Hydrophobic ion pairing-based self-emulsifying drug delivery systems: a new strategy for improving the therapeutic efficacy of water-soluble drugs41
Nuclear medicine imaging methods as novel tools in the assessment of pulmonary drug disposition41
How can we optimize the delivery of IL-2 to traumatic brain injury patients?39
Current insights into polymeric micelles for nasal drug delivery38
Enhanced skin drug delivery using dissolving microneedles: a potential approach for the management of skin disorders37
Future applications of self-immolative polymers in drug delivery37
Oral administration of M13-loaded nanoliposomes is safe and effective to treat colitis-associated cancer in mice36
A randomized crossover study assessing critical errors, preferences, and ease of use of two multidose powder inhalers36
Current status and prospect for future advancements of long-acting antibody formulations35
Engineering polycaprolactone nanowires for pharmacologic efficacy35
Continuous subcutaneous levodopa-carbidopa for the treatment of advanced Parkinson’s disease: is it an improvement on other delivery?35
Ferulic acid’s therapeutic odyssey: nano formulations, pre-clinical investigations, and patent perspective35
Stimuli-responsive image-guided nanocarriers as smart drug delivery platforms34
Innovative insight into the mechanism of enantioselective skin permeation for chiral drugs34
Recent advances in the use of liquid crystalline nanoparticles for non-small cell lung cancer treatment32
Do the chitosan nanoparticles really augment the drugs’ transdermal fluxes: ending the debate using meta-analysis32
Penetration enhancer–containing vesicles (PEVs): from deformable liposomes to barrier-modulating delivery platforms across multiple administration routes32
Small patients, big challenges: navigating pediatric drug manipulations to prevent medication errors - a comprehensive review32
Acetalated dextran: a novel delivery platform for particle-based vaccines32
Peptide amphiphile nanofibers: advanced drug delivery platforms for cardiovascular therapeutics31
Magnetoliposomes for nanomedicine: synthesis, characterization, and applications in drug, gene, and peptide delivery30
Mechanistic and translational frontiers on “VEGF and TKI inhibitor axitinib” : unfolding drug delivery approaches and opportunities in cancer therapy30
What role might nanolipogels play in enhancing drug delivery?29
Progress and potential of nanobubbles for ultrasound-mediated drug delivery29
How might intraluminal drug-delivery strategies be improved to enhance arteriovenous fistula maturation and patency?29
Calcium carbonate in drug delivery: functional carrier design, applications, and data-driven perspectives29
The potential public health benefit of live-attenuated pertussis vaccines28
Can radiopharmaceuticals be delivered by quantum dots?27
Solvent-exchange-based in situ forming implants: advances and challenges as long-lasting formulations27
Potential bladder cancer therapeutic delivery systems: a recent update27
Current insights into drug-coated balloons for peripheral arterial disease27
Bacterial and bacterial derivatives-based drug delivery systems: a novel approach for treating central nervous system disorders26
An overview of oral bioavailability enhancement through self-emulsifying drug delivery systems26
3D printed dosage forms, where are we headed?26
Differential targeting of olfactory epithelium and respiratory epithelium in nose-to-brain drug delivery26
Silica nanoparticles for brain cancer26
Cyclodextrin-based carriers for targeted drug delivery25
Critical review on the role of excipient properties in pharmaceutical powder-to-tablet continuous manufacturing25
Are stimuli-responsive hybrid copolymer nanoparticles the next innovation in tumor drug delivery?24
Carbohydrates based stimulus responsive nanocarriers for cancer-targeted chemotherapy: a review of current practices24
Emerging landscape of bioinformatics and artificial intelligence applications in cell-penetrating peptide-based delivery23
Understanding the interaction forces between shield-triggered autoinjectors and skin: an in-depth noninvasive study23
Treating glioblastoma with dextrin-based polymers23
Laser microporation facilitates topical drug delivery: a comprehensive review about preclinical development and clinical application23
Intramuscular injection of palmitic acid-conjugated Exendin-4 loaded multivesicular liposomes for long-acting and improving in-situ stability23
A technology evaluation of the atypical use of a CPP-containing peptide in the formulation and performance of a clinical botulinum toxin product23
Synthesis of a targeted, dual pH and redox-responsive nanoscale coordination polymer theranostic against metastatic breast cancer in vitro and in vivo23
Dimeric ferulic acid conjugate as a prodrug for brain targeting after nasal administration of loaded solid lipid microparticles23
Advancing the current state of gene therapies using adeno-associated virus vectors to treat atrial cardiomyopathy23
Platelets for advanced drug delivery in cancer22
Long-acting HIV pre-exposure prophylaxis (PrEP) approaches: recent advances, emerging technologies, and development challenges22
Topical film-forming systems for antifungal delivery: emerging strategies and in-depth evaluation22
Future applications of cyclic antimicrobial peptides in drug delivery22
Polymer-based thermoresponsive hydrogels for controlled drug delivery21
Particle surface coating for dry powder inhaler formulations21
Polyphosphoester cubosomes: introducing a novel drug delivery system21
Inhalation delivery of nucleic acid gene therapies in preclinical drug development21
Lipid-based nanosystems for wound healing21
Influence factors on and potential strategies to amplify receptor-mediated nanodrug delivery across the blood–brain barrier21
Development and approval of novel injectables: enhancing therapeutic innovations21
3D-printed solid oral dosage forms for mental and neurological disorders: recent advances and future perspectives20
Biphasic drug release from electrospun structures20
Pediatric inhalation therapy and the aerodynamic rationale for age-based aerosol sizes20
Is electroporation the key to drug delivery in drug-resistant cancers?19
Microneedles for oral mucosal delivery – Current trends and perspective on future directions19
Targeted transport of biotherapeutics at the blood-brain barrier19
Untethered shape-changing devices in the gastrointestinal tract19
Metered dose inhalers in the transition to low GWP propellants: what we know and what is missing to make it happen19
An evolving perspective on novel modified release drug delivery systems for inhalational therapy19
Evaluating the breadth of nucleic acid-based payloads delivered in lipid nanoparticles to establish fundamental differences in development19
Smart delivery systems for magnetic hyperthermia: the role of thermoresponsive drug delivery19
Recent advances in antibacterial nanoformulations for endodontic applications19
Sustained release of brimonidine from conjunctival sac insert to reduce intraocular pressure for glaucoma treatment18
The engineering challenges and opportunities when designing potent ionizable materials for the delivery of ribonucleic acids18
Dendrimer-mediated targeting of angiogenic biomarkers: therapeutic intervention against cancer18
Drug and stem cells delivery to salivary glands – a concise review18
Infusion-based drug delivery to the brain: what’s next?18
Where do we stand now regarding protein nanoparticles? Perspectives from the Six Thinking Hats framework18
Redox chemical delivery system: an innovative strategy for the treatment of neurodegenerative diseases17
Targeted delivery of therapeutics to the heart with calcium phosphate nanoparticles17
An interview with professor Dermot O’Toole by Zoe Kenney, commissioning editor17
Drug delivery and formulation development of hesperidin: a systematic review17
The impact of common pharmaceutical excipients on the gut microbiota17
Targeting cerebral diseases with enhanced delivery of therapeutic proteins across the blood-brain barrier16
Recent developments in nanofiber-based fast-disintegrating drug delivery systems16
Smart design of patient-centric long-acting products: from preclinical to marketed pipeline trends and opportunities16
An update on the latest strategies in retinal drug delivery16
Redox responsive cyclodextrin-based drug delivery systems: a special insight to glutathione responsive CD-nanosponges16
Engineering trafficking pathways to overcome immunosuppressive barriers in solid tumor immunotherapy16
Correction16
Drug delivery improvements to enable a flexible care setting for monoclonal antibody medications in oncology - Analogue-based decision framework16
GPP-TSAIII nanocomposite hydrogel-based photothermal ablation facilitates melanoma therapy16
Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) for the delivery of bioactives sourced from plants: part I – composition and production methods15
Development of ROS-responsive liposomes toward targeted drug delivery15
Optimizing deferoxamine delivery through the skin for pressure ulcers15
Targeting the gut microbiome to control drug pharmacomicrobiomics: the next frontier in oral drug delivery15
Nano-drug delivery system of natural products for disease prevention and treatment15
A fluid and particle mechanics perspective of nasal drug delivery15
Inhaled antifungal therapy: benefits, challenges, and clinical applications15
Biopredictive tools for the development of injectable drug products14
Subunit antigen delivery: emulsion and liposomal adjuvants for next-generation vaccines14
Explicit analysis of in vivo , meterological and statistical hurdles in successful clinical translation of targeted nanomedicines and plausible remedial 14
Future outcomes and current limitations of injectable implants for vocal fold scarring14
Biomaterials-assisted construction of neoantigen vaccines for personalized cancer immunotherapy14
Biodegradable nanoplatforms for antigen delivery: part II – nanoparticles, hydrogels, and microneedles for cancer immunotherapy14
Advanced nano-delivery systems in H. pylori eradication: targeting, efficacy, and clinical translation14
Recent advances in nanoformulation development of Ritonavir, a key protease inhibitor used in the treatment of HIV-AIDS14
Recent advances in microneedle technology in transdermal drug delivery systems14
Exploring nanoparticular platform in delivery of repurposed drug for Alzheimer’s disease: current approaches and future perspectives13
Recent advances in erythrocyte membrane-camouflaged nanoparticles for the delivery of anti-cancer therapeutics13
Re-envisioning the design of nanomedicines: harnessing automation and artificial intelligence13
Oncofetal chondroitin sulfate in cancer therapy: a promising target for anti-tumor drug delivery?13
Mucoadhesive drug delivery systems: a promising noninvasive approach to bioavailability enhancement. Part II: formulation considerations13
The pursuit of linear dosage in pharmacy: reservoir-based drug delivery systems from macro to micro scale13
Advances in plasmonic-based MOF composites, their bio-applications, and perspectives in this field13
Solid lipid nanoparticles: a promising tool for insulin delivery13
Intra-articular targeted delivery of nanomaterials for the treatment of osteoarthritis: focusing on cell signaling pathway mechanisms13
Biomaterials-assisted cancer vaccine delivery: preclinical landscape, challenges, and opportunities13
Breast cancer epidemiology, diagnostic barriers, and contemporary trends in breast nanotheranostics and mechanisms of targeting13
Rethinking probiotic delivery: new hope for preventing necrotizing enterocolitis13
0.14147400856018